文献速递心外重症与机械循环支持

使用新型双补片技术撤除左心室辅助装置

Left ventricular assist device explantation using a new double-patch technique†.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2023-01-01

本文报告两中心5例心肌功能恢复后撤除左心室辅助装置(LVAD)的经验,采用新型双补片技术。5例手术均无技术并发症,平均随访16.4±16.9个月生存率100%,无出血或血栓栓塞事件。作者认为该技术可行且安全,可停用抗凝,30天生存率100%,但需进一步研究。

要点

  • 5例LVAD撤除采用双补片技术,手术均无技术并发症。
  • 平均随访16.4±16.9个月,生存率100%,无出血或血栓栓塞事件。
  • 作者认为该技术可行且安全,可停用抗凝,需进一步研究。

核心结论

  • 使用双补片技术撤除LVAD可行且安全,该技术允许停用抗凝,30天生存率为100%。
  • 需要进一步研究以为LVAD撤除和长期随访提供更好的证据。

研究设计与样本

  • 两中心经验报告,2019年3月至2021年4月共5例患者因心肌功能恢复接受LVAD撤除(HVAD 2例,HeartMate 3 3例)。
  • 患者平均年龄50.3岁(100%男性),平均LVAD支持时间23.1±20.8个月。
  • 原发心力衰竭病因:扩张型心肌病4例,心肌炎1例。
  • 手术采用正中胸骨切开和体外循环,停LVAD并夹闭流出道人工血管,结扎并缝闭靠近主动脉吻合口处,剪断并移除驱动线,诱导颤动下从心尖袖套释放LVAD并移除,从心室腔内固定圆形心包补片封闭心尖,另加Gore-Tex补片连续缝合于心外膜缝合环上。

主要发现

  • 5例LVAD撤除手术均无技术并发症。
  • 平均随访16.4±16.9个月,生存率100%。
  • 随访期间无出血并发症或血栓栓塞事件。
  • 30天生存率为100%。

临床怎么用

  • 作者认为双补片技术撤除LVAD可行且安全,该技术允许停用抗凝。
  • 作者指出需要进一步研究以为LVAD撤除和长期随访提供更好的证据。

局限性

  • 需要进一步研究以为LVAD撤除和长期随访提供更好的证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: There are several surgical approaches for explanting a left ventricular assist device (LVAD) after recovery of cardiac function. Thus, remaining ventricular assist device components may bear significant risks of infection or thrombosis. We hereby report our technique and two-center experience with explantation of LVADs using a new double-patch technique. METHODS: From March 2019 to April 2021, five patients underwent LVAD explantation after myocardial recovery (HVAD, n = 2; HeartMate 3, n = 3). The mean patient age was 50.3 years (100% male); the mean time on the LVAD was 23.1 ± 20.8 months. The aetiology of the primary heart failure was dilated cardiomyopathy (n = 4) and myocarditis (n = 1).LVAD explantation was performed using a median sternotomy and cardiopulmonary bypass. The LVAD was stopped, and the outflow graft was clamped. The outflow graft was ligated and sutured close to the aortic anastomosis. The driveline was clipped and removed. Under induced fibrillation, the attachment of the LVAD was released from the apical cuff and the LVAD was removed. A round pericardial patch was fixed from the inner of the ventricle. This step sealed the apex of the heart. An additional Gore-Tex patch was continuously sutured epicardially over the suture ring. RESULTS: The 5 cases showed technically uncomplicated explantation of the LVADs. During the follow-up of a mean of 16.4 ± 16.9 months, we observed 100% survival. There were no bleeding complications or thromboembolic events during the follow-up period. CONCLUSIONS: LVAD explantation with the double-patch technique is feasible and safe. This technique allows discontinuation of anticoagulation. The 30-day survival was 100%. Further studies are needed to provide better evidence for LVAD explantation and long-term follow-up.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Bhadra OD, Pausch J, Aubin H, et al. Left ventricular assist device explantation using a new double-patch technique†. Interdiscip Cardiovasc Thorac Surg. 2023. PMID: 37486261. doi:10.1093/icvts/ivad110

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。